Survey of Salmonella spp. Within a swine production company transitioning to antibiotic free

As farms remove antibiotics from grow finish diets increases in Salmonella prevalence have resulted. Identification of Salmonella spp. early on can minimize future disease. The objective of this study is to determine the prevalence of Salmonella spp. in a swine production system through cross-sectional surveillance of wean-to-finish sites

Salmonella typhimurium fecal shedding following Salmonella choleraesuis-thyphimurium vaccination via drinking water and subsequent challenge

Salmonella typhimurium (ST) is a primary cause of enteritis and subclinical production losses in growing or finishing swine. Due to the zoonotic potential, intervention programs for ST have been established attempting to reduce carcass contamination. The objective of this study was to evaluate Salmonella fecal shedding of pigs vaccinated with a commercial, avirulent live culture (ALC) Salmonella Choleraesuis-Typhimurium vaccine when challenged with virulent ST

Survey of Salmonella spp. Within a swine production company transitioning to antibiotic free

As farms remove antibiotics from grow finish diets increases in Salmonella prevalence have resulted. Identification of Salmonella spp. early on can minimize future disease. The objective of this study is to determine the prevalence of Salmonella spp. in a swine production system through cross-sectional surveillance of wean-to-finish sites.</p

Salmonella typhimurium fecal shedding following Salmonella choleraesuis-thyphimurium vaccination via drinking water and subsequent challenge

Salmonella typhimurium (ST) is a primary cause of enteritis and subclinical production losses in growing or finishing swine. Due to the zoonotic potential, intervention programs for ST have been established attempting to reduce carcass contamination. The objective of this study was to evaluate Salmonella fecal shedding of pigs vaccinated with a commercial, avirulent live culture (ALC) Salmonella Choleraesuis-Typhimurium vaccine when challenged with virulent ST.</p